Investment case
ASP Isotopes Inc.
ASPI · 3 developments mapped · last assessed 2026-08-21
Market Ontology has mapped 3 macro, policy, and market developments to ASP Isotopes Inc. since 2026-08-17. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.
Valuation
No validated run has been published for ASPI yet, so no modelled value is shown. The ASPI valuation is in the public catch-up queue.
Subscribers do not wait for the weekly cycle: they run ASPI on demand, against live prices and the latest filings, and change any assumption the developments below move.
Filed financials
Current case
- Open question
ASP Isotopes Inc. to Merge Renergen Asset into ENDRA Life Sciences Inc.
Direct impact from divestiture of a significant asset and strategic refocusing. The market will evaluate the value received for Renergen and the remaining business's prospects.
· Moves future growth rate of remaining business, synergy realization from divestiture, capital allocation strategy post transaction
What changed, by assumption
- 2026-08-21ASP Isotopes Inc. to Merge Renergen Asset into ENDRA Life Sciences Inc.
- 2026-08-21ASP Isotopes Inc. to Acquire ENDRA Life Sciences Inc.
- 2026-08-17ENDRA Life Sciences Inc. to Acquire Noble Africa LLC
Assumption changes
Full ledger →| Date | Assumption | Direction | Why | Conf. |
|---|---|---|---|---|
| 2026-08-05 | Revenue | Bullish | PET Labs group forecast to deliver FY 2026 revenues of approximately $14 million, up from $6 million in 2025. | 0.90 |
| 2026-06-25 | Share count | Bullish | Stock component of consideration dilutes existing acquirer holders. | 0.70 |
| 2026-06-25 | Net debt | Bullish | Cash component of consideration is typically debt-funded, raising net debt. | 0.70 |
| 2026-06-25 | Revenue | Bullish | Acquisition adds target revenue to acquirer P&L on close. | 0.70 |
| 2026-06-23 | Cost of capital | Bullish | Higher cost-of-debt tranche lifts blended WACC. | 0.70 |
| 2026-06-23 | Interest expense | Bullish | High-yield coupon materially raises interest burden. | 0.70 |
| 2026-06-23 | Net debt | Bullish | Sub-IG debt raise increases leverage and net debt. | 0.70 |
Event impact log
Full ledger →| Date | Mechanism | Direction | Horizon | Impact |
|---|---|---|---|---|
| 2026-08-21 | ASP Isotopes Inc. to Merge Renergen Asset into ENDRA Life Sciences Inc. | mixed | 3-12m | 0.70 |
| 2026-08-21 | ASP Isotopes Inc. to Acquire ENDRA Life Sciences Inc. | mixed | 1-3m | 0.70 |
| 2026-08-17 | ENDRA Life Sciences Inc. to Acquire Noble Africa LLC | watch | 1-3m | 0.40 |